MOLECULIN BIOTECH INC (MBRX) Stock Balance Sheet
NASDAQ:MBRX - Nasdaq - US60855D3098 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 9.40M | 23.55M | 43.15M | 70.90M | 15.17M | |||
| Receivables | N/A | 1.52M | 1.05M | 496.00K | 164.00K | |||
| Other Current Assets | 2.20M | 1.20M | 1.40M | 1.10M | 1.86M | |||
| Total Current Assets | 11.61M | 26.27M | 45.60M | 72.50M | 17.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 640.00K | 796.00K | 678.00K | 445.00K | 685.00K | |||
| Intangibles | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | |||
| Total Non-Current Assets | 11.79M | 11.94M | 11.83M | 11.59M | 11.83M | |||
| TOTAL ASSETS | 23.39M | 38.22M | 57.42M | 84.09M | 29.03M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 2.95M | 4.26M | 2.64M | 2.15M | 1.71M | |||
| Accounts Payable | 2.55M | 2.50M | 2.10M | 1.36M | 1.13M | |||
| Other Current Liabilities | 90.00K | 60.00K | 86.00K | 109.00K | 78.00K | |||
| Total Current Liabilities | 5.59M | 6.82M | 4.82M | 3.62M | 2.92M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 10.32M | 5.33M | 412.00K | 1.48M | 8.35M | |||
| Total Non-Current Liabilities | 10.32M | 5.33M | 412.00K | 1.48M | 8.35M | |||
| TOTAL LIABILITIES | 15.91M | 12.14M | 5.23M | 5.10M | 11.27M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -151.49M | -131.60M | -101.83M | -72.81M | -56.92M | |||
| Additional Paid In Capital | 158.96M | 157.65M | 153.99M | 151.73M | 74.67M | |||
| Common Shares | 3.00K | 33.00K | 29.00K | 29.00K | 69.00K | |||
| Other Shareholders' Equity | 4.00K | -9.00K | 12.00K | 41.00K | -64.00K | |||
| Shares Outstanding | 3.00M | 2.23M | 1.91M | 1.91M | 769.00K | |||
| Tangible Book Value per Share | -1.22 | 6.70 | 21.50 | 35.61 | 8.60 | |||
| Total Shareholders' Equity | 7.48M | 26.07M | 52.19M | 78.99M | 17.76M | |||
| TOTAL LIABILITIES AND EQUITY | 23.39M | 38.22M | 57.42M | 84.09M | 29.03M | |||
| Statistics | ||||||||
| Current Ratio | 2.08 | 3.86 | 9.46 | 20.02 | 5.89 | |||
| Return On Assets (ROA) | -128.88% | -77.89% | -50.55% | -18.90% | -59.78% | |||
| Return On Equity (ROE) | -403.13% | -114.18% | -55.61% | -20.12% | -97.72% | |||
All data in USD , ROIC based on taxRate of 0.21